# Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Article · Gregory G. Schwartz, Philippe Gabríel Steg, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Guillaume Lecorps, Kenneth W. Mahaffey, Angèle Moryusef, Robert C. Pordy, Kirby Quintero, Matthew T. Roe, William J. Sasiela, Jean‐François Tamby, Pierluigi Tricoci, Harvey Douglas White, Andreas Michael Zeiher

- Archive id: doi:10.1056/nejmoa1801174
- Published: 2018-11-07
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa1801174
- PMID: 30403574
- Citations: 3,628
- Source URL: https://doi.org/10.1056/nejmoa1801174
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1801174?articleTools=true
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

Cited in dossiers:
- [Cardiovascular Therapeutics: State of the Field (October 2026)](https://space-kitty.com/dossiers/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.